Nanomedicine Slips Through The Cracks To Fight Cancer

Scientists in Japan have devised a nanoparticle carrier for siRNA that can access hard-to-reach tumors, such as those of the pancreas and the brain.

Embracing The Contact Sport Of Innovation

To truly harness the power of personalized medicine, we had to bring our technology out of the lab and into the marketplace. Here’s how we did it with KYAN Therapeutics.

Dual-Target Nanoparticle Reduces Lung Cancer Drug Resistance

This drug carrier nanoparticle specifically targets EGFR-mutant lung cancer cells and releases two types of drugs—doubling the effectiveness.